Takahisa Nakajo
Takahisa Nakajo has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Kentaro Tsuji-Naito
DHC Corporation Laboratories, Division 2, Chiba, Japan
5 shared publications - Takeshi Katayoshi
DHC Corporation Laboratories, Division 2, 2-42 Hamada, Mihama-ku, Chiba, 261-0025, Japan
5 shared publications - Natsuko Kitajima
DHC Corporation Laboratories, Division 2, 2-42 Hamada, Mihama-ku, Chiba, 261-0025, Japan
4 shared publications Natsuko Kitajima
DHC Corporation Laboratories, Division 2, 2-42 Hamada, Mihama-ku, Chiba, 261-0025, Japan
1 shared publication
Latest Publications
- Open Access
- 20 May 2026
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 30 (10) , e71187
Intracellular NAD + Depletion Increases Prostanoid Production via p38/ COX2 Signalling in FK866 ‐Induced Senescent Human Umbilical Vein Endothelial Cells
Vascular endothelial cells maintain vascular homeostasis by releasing mediators with vasoconstrictive and vasorelaxant effects. Prostanoids are bioactive substances synthesised by cyclooxygenase2 (COX2); they preserve vascular function and can increase the risk of cardiovascular disease (CVD) associated with ageing. Age‐related reductions in nicotinamide adenine dinucleotide (NAD + ) have been implicated in CVD pathogenesis. However, the relationship between intracellular NAD + levels and prostanoid production in vascular endothelial cells is unclear. Herein, reduced intracellular NAD + levels upregulated COX2 protein expression by activating the p38 mitogen‐activated protein kinase (MAPK) signalling pathway, increasing the production of prostaglandin F 1α (PGF 1α ) and thromboxane B 2 (TXB 2 ) in human umbilical vein endothelial cells (HUVECs). Treatment with the nicotinamide phosphoribosyltransferase (NAMPT) inhibitor, FK866, decreased intracellular NAD + levels, induced a cellular senescence‐like phenotype characterised by the suppression of cell proliferation without cell death and promoted PGF 1α and TXB 2 production in HUVECs. FK866 treatment increased phosphorylated p38 and COX2 protein levels, whereas treatment with the p38 inhibitor, PD169316, suppressed the FK866‐induced increase in COX2 expression. Supplementation with nicotinamide mononucleotide (NMN), a precursor of NAD + , following FK866 treatment restored intracellular NAD + levels, reduced the cellular senescence‐like phenotype and attenuated the production of PGF 1α and TXB 2 . These results suggest that intracellular NAD + appears to regulate prostanoid production in HUVECs under conditions of acute depletion.
- 20 May 2026
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 30 (10) , e71187
Open AccessIntracellular NAD + Depletion Increases Prostanoid Production via p38/ COX2 Signalling in FK866 ‐Induced Senescent Human Umbilical Vein Endothelial Cells
Vascular endothelial cells maintain vascular homeostasis by releasing mediators with vasoconstrictive and vasorelaxant effects. Prostanoids are bioactive substances synthesised by cyclooxygenase2 (COX2); they preserve vascular function and can increase the risk of cardiovascular disease (CVD) associated with ageing. Age‐related reductions in nicotinamide adenine dinucleotide (NAD + ) have been implicated in CVD pathogenesis. However, the relationship between intracellular NAD + levels and prostanoid production in vascular endothelial cells is unclear. Herein, reduced intracellular NAD + levels upregulated COX2 protein expression by activating the p38 mitogen‐activated protein kinase (MAPK) signalling pathway, increasing the production of prostaglandin F 1α (PGF 1α ) and thromboxane B 2 (TXB 2 ) in human umbilical vein endothelial cells (HUVECs). Treatment with the nicotinamide phosphoribosyltransferase (NAMPT) inhibitor, FK866, decreased intracellular NAD + levels, induced a cellular senescence‐like phenotype characterised by the suppression of cell proliferation without cell death and promoted PGF 1α and TXB 2 production in HUVECs. FK866 treatment increased phosphorylated p38 and COX2 protein levels, whereas treatment with the p38 inhibitor, PD169316, suppressed the FK866‐induced increase in COX2 expression. Supplementation with nicotinamide mononucleotide (NMN), a precursor of NAD + , following FK866 treatment restored intracellular NAD + levels, reduced the cellular senescence‐like phenotype and attenuated the production of PGF 1α and TXB 2 . These results suggest that intracellular NAD + appears to regulate prostanoid production in HUVECs under conditions of acute depletion.
- Open Access
- 6 July 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 731, 150371
NAD+ overconsumption by poly (ADP-ribose) polymerase (PARP) under oxidative stress induces cytoskeletal disruption in vascular endothelial cell
- 6 July 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 731, 150371
Open AccessNAD+ overconsumption by poly (ADP-ribose) polymerase (PARP) under oxidative stress induces cytoskeletal disruption in vascular endothelial cell
- Open Access
- 27 October 2023
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 36, 101561
Nucleotide-binding oligomerization domain protein-1 is expressed and involved in the inflammatory response in human sebocytes
- 27 October 2023
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 36, 101561
Open AccessNucleotide-binding oligomerization domain protein-1 is expressed and involved in the inflammatory response in human sebocytes
- 26 August 2023
- Published by Elsevier in Toxicology in Vitro
- Vol. 93, 105683
Nicotinamide mononucleotide inhibits oxidative stress-induced damage in a SIRT1/NQO-1-dependent manner
- 26 August 2023
- Published by Elsevier in Toxicology in Vitro
- Vol. 93, 105683
Nicotinamide mononucleotide inhibits oxidative stress-induced damage in a SIRT1/NQO-1-dependent manner
- Open Access
- 1 December 2021
- Published by Elsevier in Redox Biology
- Vol. 48, 102203
1,25-Dihydroxyvitamin D3 attenuates IL-1β secretion by suppressing NLRP1 inflammasome activation by upregulating the NRF2-HO-1 pathway in epidermal keratinocytes
- 1 December 2021
- Published by Elsevier in Redox Biology
- Vol. 48, 102203
Open Access1,25-Dihydroxyvitamin D3 attenuates IL-1β secretion by suppressing NLRP1 inflammasome activation by upregulating the NRF2-HO-1 pathway in epidermal keratinocytes